Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jphs.2022.01.001 | DOI Listing |
Publication Analysis
Top Keywords
corrigendum 'nafamostat
4
'nafamostat protects
4
protects early
4
early brain
4
brain injury
4
injury subarachnoid
4
subarachnoid hemorrhage
4
hemorrhage mice'
4
mice' [journal
4
[journal pharmacological
4
Similar Publications
Corrigendum to 'Nafamostat protects against early brain injury after subarachnoid hemorrhage in mice' [Journal of Pharmacological Sciences 148 (2022) 65-72].
J Pharmacol Sci
February 2022
Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan. Electronic address:
Corrigendum to "Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis" [Cancer Lett. 380 (2016) 87-97].
Cancer Lett
January 2020
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!